The twiist insulin pump from Sequel Med Tech is releasing in Q2 of 2025. is bringing a new spin to tubed pump therapy. I met with Sequel's CEO to dive into twiist's launch CGM integration with Libre 3 Plus to its advanced occlusion technology designed for more reliable insulin delivery. We also break down how patients will access twiist through pharmacy benefit managers, a shift that could make the pump more accessible. For more coverage on the biggest diabetes tech announcements at ATTD, check out my social (@diabe_tech) and our recent podcast episode covering the biggest news!

Learn about Omnipod 5 (today's sponsor)*

T1D Exchange Registry Sign up  (US residents only)

Watch This Episode On Youtube

Watch Next: twiist First Look | twiist Explained

Join our Newsletter | Support us on Patreon 

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.